Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ do Nascimento, G. R. da Silva Santos, A. C. Silva, N. N. T. Guilmaraes, N. S. Lima, A. A. Coura-Vital, W.

Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Xu, H. Tiffany, A. Luquero, F. J. Kanungo, S. Bwire, G. Qadri, F. Garone, D. Ivers, L. C. Lee, E. C. Malembaka, E. B. Mendiboure, V. Bouhenia, M. Breakwell, L. Azman, A. S.

Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis

  • All age groups
  • Cholera
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Mariscal-Lopez, E. Agredano-Sanchez, M. Lopez-Gigosos, R. M. Mariscal, A. Farinas-Guerrero, F. Gutierrez-Bedmar, M. Guts-Chornoknyzha, M.

Protective effect of adult vaccination on the development of dementias: A systematic review

  • Adults
  • Older adults
  • Influenza
  • Tetanus
  • Diphtheria
  • Pertussis
  • Herpes zoster
  • Pneumococcal disease
  • Tuberculosis
  • Rabies
  • Hepatitis A
  • Typhoid
  • Hepatitis B
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Patel, V. Korsun, M. Cervia, J.

Protective effects of booster dose of SARS-COV-2 vaccination against post-acute COVID-19 syndrome: A systematic review

  • Adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Ekhator, E. Essien, V. G. Afolabi, O. E. Okundaye, M. I. Adewonbi, T.

Public awareness and acceptance of malaria vaccine in Sub-Saharan Africa: a systematic review

  • Africa
  • Parents/caregivers
  • Malaria
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Katsandres, S. C. Scheele, S. K. Kiener, T. Bloudek, L.

Public Health Impact of the MVA-BN Vaccine During the 2022 Mpox Outbreak: A Systematic Review

  • All age groups
  • Mpox
  • Modeling
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Lee, B. Trusinska, D. Ferdous, S. Pei, R. Kwok, H. H. Y. Schwarze, J. Williams, T. C. Gibbons, C. Quint, J. K. Sheikh, A. Drysdale, S. B. Shi, T.

Real-world effectiveness and safety of nirsevimab, RSV maternal vaccine and RSV vaccines for older adults: a living systematic review and meta-analysis

  • Pregnant women
  • Adults
  • Older adults
  • RSV (Respiratory syncytial virus)
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Stuurman, A. L. Enxing, J. Gutierrez, A. V. Gray, C. M. Sepulveda-Pachon, I. T. Ubamadu, E. Bandell, A. Taylor, S. El Azzi, G. Meeraus, W.

Real-world effectiveness of live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) in children from 2003 to 2023: a systematic literature review and network meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Adults
  • Influenza
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Trusinska, D. Lee, B. Ferdous, S. Kwok, H. H. Y. Gordon, B. Gao, J. Ma, L. Xiong, H. Sheikh, S. A. Schwarze, J. Busby, J. Gibbons, C. Drysdale, S. B. Ritchie, S. L. Williams, T. Shi, T.

Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis

  • Newborn
  • Children
  • Adults
  • Older adults
  • Pregnant women
  • RSV (Respiratory syncytial virus)
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Haposan, J. H. Icanervilia, A. V. Watts, E. Widyaningsih, S. A. Ulfa, S. Widayanti, P. Laksanawati, I. S. At Thobari, J. Bines, J. E.

Real-world vaccine effectiveness of typhoid conjugate vaccine in children and adolescents: a systematic review and meta-analysis

  • Newborn
  • Children
  • Adolescents
  • Typhoid
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...